INSIDER · CIK 2095702
Bulis Veronica Sanchez
VP, Corporate Controller at Lyell Immunopharma, Inc. (LYEL)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$9KSold on the market
1Companies
Aug 11, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 202616:21 | Aug 10, 2026 | LYELLyell Immunopharma, Inc. | VP, Corporate Controller | S · Sell | $14.34 | −621 | 14,799 | -4% | −$9K |